Terms: = Pancreatic cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Treatment
228 results:
1. [A Case of Advanced Gastric cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy].
Sekino N; Natsume T; Tanaka H; Kainuma O; Sato Y; Note H; Yoshioka T; Kamata T; Odera H; Uchiyama M; Maruyama T; Takahashi H; Hirano S
Gan To Kagaku Ryoho; 2024 Apr; 51(4):417-420. PubMed ID: 38644309
[TBL] [Abstract] [Full Text] [Related]
2. PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report.
Kong YH; Xu ML; Zhang JJ; Chen GQ; Hong ZH; Zhang H; Dai XX; Ma YF; Zhao XR; Zhang CY; Chen RZ; Xing PF; Zhang LY
World J Gastroenterol; 2024 Mar; 30(9):1237-1249. PubMed ID: 38577174
[TBL] [Abstract] [Full Text] [Related]
3. [The use of targeted therapies in gastrointestinal oncology].
Lange S
Dtsch Med Wochenschr; 2024 Apr; 149(8):440-446. PubMed ID: 38565117
[TBL] [Abstract] [Full Text] [Related]
4. MNX1 Promotes Anti-her2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in her2-Positive Breast cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract] [Full Text] [Related]
5. Prioritization of Fluorescence In Situ Hybridization (FISH) Probes for Differentiating Primary Sites of neuroendocrine Tumors with Machine Learning.
Pietan L; Vaughn H; Howe JR; Bellizzi AM; Smith BJ; Darbro B; Braun T; Casavant T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139230
[TBL] [Abstract] [Full Text] [Related]
6. The genomic and immune landscapes of gastric cancer and their correlations with her2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
7. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and Safety of Trastuzumab Deruxtecan in Patients With her2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.
Meric-Bernstam F; Makker V; Oaknin A; Oh DY; Banerjee S; González-Martín A; Jung KH; Ługowska I; Manso L; Manzano A; Melichar B; Siena S; Stroyakovskiy D; Fielding A; Ma Y; Puvvada S; Shire N; Lee JY
J Clin Oncol; 2024 Jan; 42(1):47-58. PubMed ID: 37870536
[TBL] [Abstract] [Full Text] [Related]
9. Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract cancer (SGNTUC-019): A Phase II Basket Study.
Nakamura Y; Mizuno N; Sunakawa Y; Canon JL; Galsky MD; Hamilton E; Hayashi H; Jerusalem G; Kim ST; Lee KW; Kankeu Fonkoua LA; Monk BJ; Nguyen D; Oh DY; Okines A; O'Malley DM; Pohlmann P; Reck M; Shin SJ; Sudo K; Takahashi S; Van Marcke C; Yu EY; Groisberg R; Ramos J; Tan S; Stinchcombe TE; Bekaii-Saab T
J Clin Oncol; 2023 Dec; 41(36):5569-5578. PubMed ID: 37751561
[TBL] [Abstract] [Full Text] [Related]
10. ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle.
Yang H; Zhen X; Yang Y; Zhang Y; Zhang S; Hao Y; Du G; Wang H; Zhang B; Li W; Wang J
J Exp Clin Cancer Res; 2023 Sep; 42(1):227. PubMed ID: 37667329
[TBL] [Abstract] [Full Text] [Related]
11. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids.
Beelen NA; Aberle MR; Bruno V; Olde Damink SWM; Bos GMJ; Rensen SS; Wieten L
Front Immunol; 2023; 14():1133796. PubMed ID: 37520563
[TBL] [Abstract] [Full Text] [Related]
12. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
13. Gastric Amphicrine Carcinoma Showing neuroendocrine and pancreatic Acinar Cell Differentiation. Lesson from a Challenging Case Opening New Perspectives in the Diagnostic Work-Up of Gastric neuroendocrine Neoplasms.
Sciarra A; Uccella S; Hiroz P; Fournier I; Soubeyran V; Finzi G; La Rosa S
Endocr Pathol; 2023 Sep; 34(3):349-357. PubMed ID: 37249796
[TBL] [Abstract] [Full Text] [Related]
14. The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal cancers.
Lee MS; Kaseb AO; Pant S
Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904
[TBL] [Abstract] [Full Text] [Related]
15. The role of claudin 18.2 and her-2 in pancreatic cancer outcomes.
Kayikcioglu E; Yüceer RO
Medicine (Baltimore); 2023 Feb; 102(6):e32882. PubMed ID: 36820561
[TBL] [Abstract] [Full Text] [Related]
16. The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer.
Pei XM; Wong HT; Ng SSM; Leung WW; Wong YN; Tsang HF; Chan AKC; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Chan JKC; Wong KF; Luk JM; Tai WCS; Wong SCC
Expert Rev Mol Diagn; 2023 Feb; 23(2):171-179. PubMed ID: 36744385
[TBL] [Abstract] [Full Text] [Related]
17. Successful second conversion surgery after trastuzumab deruxtecan for recurrent her2-positive gastric cancer.
Terashima T; Yamashita T; Takabatake H; Nakanuma S; Kinoshita J; Yagi S; Mizukoshi E; Harada K; Fushida S; Kaneko S
Clin J Gastroenterol; 2023 Jun; 16(3):330-335. PubMed ID: 36708503
[TBL] [Abstract] [Full Text] [Related]
18. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive cancer Centre.
Scheiter A; Hierl F; Lüke F; Keil F; Heudobler D; Einhell S; Klier-Richter M; Konstandin NP; Weber F; Scheiter A; Kandulski A; Schlosser S; Cosma LS; Tews H; Weiss ARR; Grube M; Bumes E; Hau P; Proescholdt M; Steger F; Troeger A; Haferkamp S; Reibenspies LE; Schnabel MJ; Schulz C; Drexler K; Hatzipanagiotou ME; Seitz S; Klinkhammer-Schalke M; Unberath P; Calvisi DF; Pukrop T; Dietmaier W; Evert M; Utpatel K
Br J Cancer; 2023 Apr; 128(6):1134-1147. PubMed ID: 36572733
[TBL] [Abstract] [Full Text] [Related]
19. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
[TBL] [Abstract] [Full Text] [Related]
20. Druggable gene alterations in Japanese patients with rare malignancy.
Ohmoto A; Hayashi N; Fukada I; Yamazaki M; Yunokawa M; Kasuga A; Shinozaki E; Ueki A; Tonooka A; Takeuchi K; Mori S; Kiyotani K; Takahashi S
Neoplasia; 2022 Nov; 33():100834. PubMed ID: 36088851
[TBL] [Abstract] [Full Text] [Related]
[Next]
